We developed the Criteria for the clinical use of immunoglobulin in Australia (the Criteria) using specialist working groups of expert clinicians to identify th
All health providers in Australia are required to manage blood and blood products in ways that ensure transfusion-related adverse event information is collected
The National Patient Blood Management Implementation Strategy 2017-2024 takes a patient-centred approach intended to optimise clinical outcomes and improve pati
